Published in Arch Intern Med on January 01, 1983
Etiological agent and primary source of infection in 42 cases of focal intracranial suppuration. J Clin Microbiol (1986) 0.96
Gradenigo's syndrome with lateral venous sinus thrombosis: successful conservative treatment. Eur J Pediatr (2009) 0.86
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Ann Oncol (2009) 5.08
Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med (1995) 4.38
Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis (1992) 3.37
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol (2000) 3.23
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
Colossal ionic conductivity at interfaces of epitaxial ZrO2:Y2O3/SrTiO3 heterostructures. Science (2008) 2.99
Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother (1992) 2.86
Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med (1987) 2.78
Environmental risk factors for REM sleep behavior disorder: a multicenter case-control study. Neurology (2012) 2.54
Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother (1998) 2.40
Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet (1999) 2.30
Pediatric analgesia and sedation. Ann Emerg Med (1994) 2.25
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med (1988) 2.24
Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol (2004) 2.22
Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother (1991) 2.13
Specific antibody profile in human brucellosis. Clin Infect Dis (1992) 2.08
[Current treatment of pneumococcal meningitis]. Enferm Infecc Microbiol Clin (1991) 2.02
Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii. J Antimicrob Chemother (1998) 2.00
Effects of antibiotics on protected specimen brush sampling in ventilator-associated pneumonia. Eur Respir J (2002) 2.00
Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis (2003) 1.92
Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med (2001) 1.85
Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1994) 1.85
Relevance of digestive tract colonization in the epidemiology of nosocomial infections due to multiresistant Acinetobacter baumannii. Clin Infect Dis (1996) 1.68
Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med (2010) 1.68
Characteristics of and risk factors for relapse of brucellosis in humans. Clin Infect Dis (1995) 1.67
Streptococcal meningitis in adult patients: current epidemiology and clinical spectrum. Clin Infect Dis (1999) 1.66
Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol (1978) 1.65
Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Antimicrob Agents Chemother (1985) 1.63
Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med (1996) 1.61
Risk factors for nosocomial Legionella pneumophila pneumonia. Am J Respir Crit Care Med (1994) 1.61
Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect (1997) 1.58
Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med (1995) 1.58
Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ann Intern Med (1992) 1.58
What is the relationship between arachnoid cysts and seizure foci? Epilepsia (1997) 1.58
Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob Agents Chemother (1996) 1.51
Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49
[Cytomegalovirus disease in patients with acquired immunodeficiency syndrome. Report of 63 cases]. Med Clin (Barc) (1993) 1.47
Community-acquired bacteremic Pseudomonas cepacia pneumonia in an immunocompetent host. Clin Infect Dis (1992) 1.47
Giant magnetoresistance in ferromagnet/superconductor superlattices. Phys Rev Lett (2005) 1.39
Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reaction due to nevirapine. AIDS (2000) 1.38
Unexplained bleeding in a patient with mechanical valve prostheses. Am J Med (1988) 1.37
Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer. Clin Infect Dis (1995) 1.36
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother (1995) 1.35
Specific antibodies detected during relapse of human brucellosis. J Infect Dis (1988) 1.33
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Etiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis (2001) 1.30
Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis (1994) 1.27
Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clin Infect Dis (1995) 1.27
Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: similarities and differences on presentation. Eur Respir J (1989) 1.26
Efficacy of colistin versus beta-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother (2002) 1.26
Infections due to Escherichia coli producing extended-spectrum beta-lactamase among hospitalised patients: factors influencing mortality. J Hosp Infect (2008) 1.23
Serious complications of bacteremia caused by Viridans streptococci in neutropenic patients with cancer. Clin Infect Dis (2000) 1.21
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother (1996) 1.20
Pneumococcal peritonitis in adult patients: report of 64 cases with special reference to emergence of antibiotic resistance. Arch Intern Med (2001) 1.19
Group B streptococcal disease in nonpregnant adults: incidence, clinical characteristics, and outcome. Eur J Clin Microbiol Infect Dis (2004) 1.18
Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis (2000) 1.18
Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1999) 1.17
Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications. Clin Microbiol Infect (2007) 1.16
Risk-factors for acquisition of extended-spectrum beta-lactamase-producing Escherichia coli among hospitalised patients. Clin Microbiol Infect (2006) 1.16
Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother (1986) 1.16
Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med (1998) 1.14
Comparative trial of co-trimoxazole versus tetracycline-streptomycin in treating human brucellosis. J Infect Dis (1985) 1.14
Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients. Antimicrob Agents Chemother (2007) 1.14
Protected bronchoalveolar lavage in the diagnosis of ventilator-associated pneumonia. Eur Respir J (1996) 1.13
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.13
High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother (1996) 1.11
Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother (1999) 1.10
Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia. Eur J Clin Microbiol Infect Dis (1999) 1.09
Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis (1997) 1.08
Efficacy of high doses of daptomycin versus alternative therapies against experimental foreign-body infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2009) 1.07
Brucellar spondylitis: a detailed analysis based on current findings. Rev Infect Dis (1985) 1.07
Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother (1995) 1.07
Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia. Eur J Clin Microbiol Infect Dis (2006) 1.07
Early mortality in patients with community-acquired pneumonia: causes and risk factors. Eur Respir J (2008) 1.06
Upper limit to magnetism in LaAlO3/SrTiO3 heterostructures. Phys Rev Lett (2011) 1.06
An investigation of the early effects of manual lung hyperinflation in critically ill patients. Anaesth Intensive Care (2000) 1.05
Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect (2009) 1.05
Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med (1993) 1.04
Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain. Clin Microbiol Infect (2010) 1.04
Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis (1996) 1.04
An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase. J Hosp Infect (2001) 1.03
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect (2011) 1.03
Continuous positive air pressure eliminates nocturnal stridor in multiple system atrophy. Barcelona Multiple System Atrophy Study Group. Lancet (2000) 1.00
Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax (2009) 1.00
Giant-cell arteritis presenting with ipsilateral hemiplegia and lateral medullary syndrome. Eur Neurol (1989) 0.99
Statins for community-acquired pneumonia: current state of the science. Eur J Clin Microbiol Infect Dis (2009) 0.99
Management of methicillin-resistant Staphylococcus aureus infections. Clin Microbiol Infect (2009) 0.99
Epidemiology and prognosis of bacteremia: a 10-y study in a community hospital. Scand J Infect Dis (2002) 0.99
Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J (2011) 0.98
Characteristic cutaneous lesions in patients with brucellosis. Arch Dermatol (1989) 0.97
Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy. Neurology (2004) 0.97